$VRTX VERTEX PHARMACEUTICALS INC / MA Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in VERTEX PHARMACEUTICALS INC / MA. Find out how many shares they currently own, their value and whether they buy or sell their shares.
VERTEX PHARMACEUTICALS INC / MA Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| ALAM JOHN J | EVP, Med. Dev. Group & CMO | 136,792 | 11,879,017 | Oct 02 2008 | |||
| ALTSHULER DAVID | EVP, Global Research and CSO | 36,617 | 3,179,820 | Feb 26 2021 | |||
| ALTSHULER DAVID | EVP, Global Research and CSO | 75,000 | 6,513,000 | Jan 13 2015 | |||
| Arbuckle Stuart A | EVP, Chief Commercial Officer | 44,737 | 3,884,961 | Feb 26 2021 | |||
| Arbuckle Stuart A | EVP\Chief Commercial Officer | 138,270 | 12,007,367 | Feb 05 2015 | |||
| Bhatia Sangeeta N. | Director | 14,424 | 1,252,580 | Oct 07 2020 | |||
| BOGER JOSHUA S | Director | 284,088 | 24,670,202 | Jun 09 2017 | |||
| BOGER JOSHUA S | Director | 632,895 | 54,960,602 | Jun 08 2012 | |||
| BOGER JOSHUA S | Director | 338,895 | 29,429,642 | Dec 05 2013 | |||
| BOGER JOSHUA S | Director | 338,895 | 29,429,642 | Feb 20 2015 | |||
| BOGER KENNETH S | SVP & General Counsel | 116,752 | 10,138,744 | Feb 07 2011 | |||
| BOGER KENNETH S | SVP & Chief Legal Officer | 112,999 | 9,812,833 | Sep 14 2011 | |||
| Bozic Carmen | EVP and CMO | 33,264 | 2,888,646 | Feb 26 2021 | |||
| BRANDT ERIC | Director | 0 | 0 | Jan 30 2009 | |||
| BRIMBLECOMBE ROGER W | Director | 0 | 0 | Mar 16 2010 | |||
| BRUM LYNNE H | VP, Strategic Communications | 46,199 | 4,011,921 | May 09 2006 | |||
| BUCHANAN IAIN P M | VP, European Operations | 22,094 | 1,918,643 | May 10 2004 | |||
| CARNEY LLOYD | Director | 5,401 | 469,023 | May 04 2021 | |||
| Chodakewitz Jeffrey | EVP GMDA, CMO | 64,660 | 5,615,074 | Feb 08 2018 | |||
| Chodakewitz Jeffrey | SVP GMDA, CMO | 0 | 0 | Jul 17 2014 | |||
| Chodakewitz Jeffrey | EVP GMDA, CMO | 100,562 | 8,732,804 | Feb 05 2015 | |||
| COLES N ANTHONY | SVP, Comm. Ops. | 74,540 | 6,473,054 | Jul 22 2005 | |||
| COLLINSON STUART J | Director | 3,279 | 284,748 | Jun 02 2010 | |||
| Connolly Thomas | SVP, Human Resources | 3,772 | 327,560 | Dec 12 2013 | |||
| Connolly Thomas | SVP, Human Resources | 34,375 | 2,985,125 | Dec 16 2014 | |||
| CORDES EUGENE | Director | 14,000 | 1,215,760 | Jun 02 2010 | |||
| CORDES EUGENE | Director | 12,000 | 1,042,080 | Mar 18 2011 | |||
| Emmens Matthew | President & CEO | 229,406 | 19,921,617 | Feb 07 2011 | |||
| Emmens Matthew | Director | 211,601 | 18,375,431 | Jun 01 2012 | |||
| Emmens Matthew | Director | 200,873 | 17,443,811 | Nov 20 2012 | |||
| Garber Alan M | Director | 5,890 | 511,488 | May 04 2021 | |||
| GARRISON RICHARD C | SVP and Catalyst | 37,473 | 3,254,155 | May 19 2009 | |||
| Graney Thomas | Chief Financial Officer | 12,430 | 1,079,421 | Oct 02 2018 | |||
| Graves Kurt | EVP, Chief Commercial Officer | 59,880 | 5,199,979 | Oct 21 2009 | |||
| Hartmann Victor A | EVP, Strategic & Corp. Devlp. | 97,273 | 8,447,187 | Jun 05 2007 | |||
| Horton Kenneth L | EVP & Chief Legal Officer | 16,624 | 1,443,628 | Dec 12 2013 | |||
| Horton Kenneth L | EVP & Chief Legal Officer | 72,053 | 6,257,083 | Nov 19 2014 | |||
| Howton David T | SVP & Chief Legal Officer | 19,437 | 1,687,909 | Feb 06 2012 | |||
| Kearney Terrence C | Director | 10,811 | 938,827 | May 04 2021 | |||
| Kearney Terrence C | Director | 0 | 0 | Jun 04 2013 | |||
| Kearney Terrence C | Director | 0 | 0 | Jun 03 2014 | |||
| Kelly Lisa | SVP, Human Resources | 42,242 | 3,668,295 | Mar 01 2011 | |||
| Kelly Lisa | SVP, Human Resources | 17,249 | 1,497,903 | May 29 2012 | |||
| Kelly Lisa | SVP, Human Resources | 25,382 | 2,204,173 | Feb 07 2013 | |||
| Kewalramani Reshma | CEO & President | 63,643 | 5,526,758 | Feb 26 2021 | |||
| Lee Yuchun | Director | 3,000 | 260,520 | May 04 2021 | |||
| Lee Yuchun | Director | 0 | 0 | Jun 04 2013 | |||
| Lee Yuchun | Director | 0 | 0 | Jun 03 2014 | |||
| LEIDEN JEFFREY M | Executive Chairman | 33,809 | 2,935,974 | Feb 05 2021 | |||
| LEIDEN JEFFREY M | Director | 2,600 | 225,784 | Dec 17 2010 | |||
| LEIDEN JEFFREY M | CEO Designate | 185,995 | 16,151,806 | Dec 16 2011 | |||
| LEIDEN JEFFREY M | CEO & President | 182,925 | 15,885,207 | Dec 12 2013 | |||
| LEIDEN JEFFREY M | CEO & President | 249,927 | 21,703,661 | Feb 20 2015 | |||
| Lewis-Hall Freda C | EVP, Medicines Development | 53,334 | 4,631,525 | Mar 20 2009 | |||
| MCGLYNN MARGARET G | Director | 1,798 | 156,138 | May 04 2021 | |||
| MCGLYNN MARGARET G | Director | 0 | 0 | Jun 01 2012 | |||
| MCGLYNN MARGARET G | Director | 1,000 | 86,840 | Jun 04 2013 | |||
| MCGLYNN MARGARET G | Director | 0 | 0 | Jun 03 2014 | |||
| MCKENZIE DIANA | Director | 3,277 | 284,575 | May 04 2021 | |||
| MUELLER PETER | EVP, Global R&D, CSO | 133,735 | 11,613,547 | Feb 07 2011 | |||
| MUELLER PETER | EVP, Global R&D, CSO | 132,316 | 11,490,321 | May 16 2012 | |||
| MUELLER PETER | EVP, Global R&D, CSO | 141,500 | 12,287,860 | Dec 17 2013 | |||
| MUELLER PETER | EVP, Global R&D, CSO | 143,517 | 12,463,016 | Jun 18 2014 | |||
| Negulescu Paul A | VP, Research | 55,516 | 4,821,009 | Feb 07 2005 | |||
| NIBLACK JOHN F | Director | 0 | 0 | Jun 02 2004 | |||
| Pace Megan E | SVP, Corp. Communications | 12,188 | 1,058,406 | Dec 12 2013 | |||
| Pace Megan E | SVP, Corp. Communications | 43,350 | 3,764,514 | Nov 19 2014 | |||
| Parini Michael | EVP, Chief Adm, Leg & BD Off | 33,865 | 2,940,837 | Feb 26 2021 | |||
| POWER JOHANNA MESSINA | VP & Controller | 9,055 | 786,336 | Jul 25 2008 | |||
| Riley Wayne Joseph | Director | 400 | 34,736 | Jun 03 2015 | |||
| Riley Wayne Joseph | Director | 0 | 0 | Jul 13 2010 | |||
| Riley Wayne Joseph | Director | 0 | 0 | Jun 01 2012 | |||
| Riley Wayne Joseph | Director | 200 | 17,368 | Jul 31 2013 | |||
| Riley Wayne Joseph | Director | 400 | 34,736 | Jan 13 2015 | |||
| Sachdev Amit | EVP, Chief Patient Officer | 44,017 | 3,822,436 | Apr 29 2021 | |||
| Sachdev Amit | SVP, Corp Affairs & Pub Policy | 31,108 | 2,701,419 | May 09 2012 | |||
| Sachdev Amit | SVP, Global Gov. Strategy | 26,561 | 2,306,557 | Dec 12 2013 | |||
| Sachdev Amit | EVP, Policy, Access & Value | 89,984 | 7,814,211 | Feb 20 2015 | |||
| SACHS BRUCE I | Director | 18,035 | 1,566,159 | Apr 16 2021 | |||
| SACHS BRUCE I | Director | 21,210 | 1,841,876 | Jan 22 2015 | |||
| SACHS BRUCE I | Director | 181,210 | 15,736,276 | Jun 01 2012 | |||
| SACHS BRUCE I | Director | 46,510 | 4,038,928 | Dec 26 2013 | |||
| SANDERS CHARLES A | Director | 26,383 | 2,291,100 | Jun 02 2010 | |||
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 35,068 | 3,045,305 | May 05 2021 | |||
| SATO VICKI L | President | 77,233 | 6,706,914 | May 12 2005 | |||
| Silva Paul M | SVP & Chief Accounting Officer | 12,666 | 1,099,915 | Mar 02 2021 | |||
| Silva Paul M | SVP & Corp Controller | 6,125 | 531,895 | May 16 2012 | |||
| Silva Paul M | SVP & Corp Controller | 11,750 | 1,020,370 | Nov 06 2013 | |||
| Silva Paul M | SVP & Corp Controller | 20,625 | 1,791,075 | Feb 20 2015 | |||
| Slater Eve Elizabeth | Director | 1,105 | 95,958 | Jun 04 2007 | |||
| SMITH IAN F | EVP, COO | 70,074 | 6,085,226 | Jul 03 2018 | |||
| SMITH IAN F | EVP & CFO | 24,168 | 2,098,749 | Feb 09 2012 | |||
| SMITH IAN F | EVP & CFO | 24,168 | 2,098,749 | Aug 01 2013 | |||
| SMITH IAN F | EVP & CFO | 124,176 | 10,783,444 | Feb 20 2015 | |||
| Stamoulis Christiana | SVP, Corp Strategy & Bus Devlp | 23,813 | 2,067,921 | Feb 07 2011 | |||
| Stamoulis Christiana | SVP, Corp Strategy & Bus Devlp | 40,712 | 3,535,430 | Aug 01 2013 | |||
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 32,468 | 2,819,521 | Feb 19 2021 | |||
| ULLIAN ELAINE | Director | 12,195 | 1,059,014 | Jun 04 2019 | |||
| ULLIAN ELAINE | Director | 5,265 | 457,213 | Jun 04 2013 | |||
| ULLIAN ELAINE | Director | 5,265 | 457,213 | Jan 06 2015 | |||
| ULLIAN ELAINE | Director | 5,000 | 434,200 | Jun 02 2010 | |||
| ULLIAN ELAINE | Director | 5,265 | 457,213 | Jun 01 2012 | |||
| Vertex Pharmaceuticals (Europe) Ltd | 10% Owner | 5,353,479 | 464,896,116 | Dec 28 2018 | |||
| VERTEX PHARMACEUTICALS INC / MA | 10% Owner | 0 | 0 | Aug 02 2006 | |||
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 34,679 | 3,011,524 | May 05 2021 | |||
| WINGER DENNIS L | Director | 6,500 | 564,460 | Jun 02 2010 | |||
| WINGER DENNIS L | Director | 6,500 | 564,460 | Mar 12 2012 | |||
| Wysenski Nancy | EVP & Chief Commercial Officer | 32,084 | 2,786,175 | Feb 07 2011 | |||
| Wysenski Nancy | EVP, Chief Commercial Officer | 32,232 | 2,799,027 | May 16 2012 | |||
| YOUNG WILLIAM D | Director | 29,311 | 2,545,367 | Jun 03 2020 | |||
| YOUNG WILLIAM D | Director | 0 | 0 | Jun 03 2014 |